Recent News

Researchers are Studying the Mesothelioma Tumor Microenvironment

February 11, 2022

A new study is showing how the tumor microenvironment helps mesothelioma progress and survive in the body. Mesothelioma tumors create a complex microenvironment surrounding themselves. The microenvironment is simply the[…]

Different Levels of Pleurectomy and Decortication Surgery can Save Mesothelioma Patients’ Lives

February 4, 2022

Italian researchers believe that lung sparing surgery can improve survival in mesothelioma patients, even when surgeries are more conservative. Pleurectomy and decortication is the surgery that spares the lungs. It[…]

A Virus that Affects Goats Could Help Treat Mesothelioma

January 28, 2022

Mesothelioma, a cancer of the membrane that surrounds the lungs, abdomen, heart, and testicles is a very aggressive cancer. It spreads very quickly and when the tumors grow big enough,[…]

Epigenetics Used to Improve Immunotherapy for Mesothelioma

January 21, 2022

Researchers are looking into changing mesothelioma cells to make them more susceptible to immunotherapy. Mesothelioma is a hard cancer to treat, so new approaches need to be developed to try[…]

LMB-100 and Ipilumab Combination Being Tested for Pleural and Peritoneal Mesothelioma

January 14, 2022

The National Cancer Institute just started a study to see if it could make immunotherapy more potent for treating mesothelioma. The study combines a manmade protein that kills cancer cells[…]

GPX-1 Could be used as a Biomarker for Mesothelioma

January 7, 2022

An enzyme that helps clean up the byproducts of cellular oxidation could potentially be a biomarker for pleural mesothelioma. People with very small amounts of the enzyme were found to[…]

UCARTMESO CAR-T Cell Therapy Can Help Kill Mesothelioma Cells

December 17, 2021

A new treatment utilizing CAR-T cell therapy could help prevent mesothelioma cells from protecting themselves. The treatment, called UCARTMESO, is being developed by the French biopharmaceutical company Cellectis. The treatment[…]

Durvalumab and Chemotherapy Extends Mesothelioma Patients’ Lives

December 10, 2021

Studies are showing that the immunotherapy drug durvalumab can make chemotherapy more effective for treating mesothelioma. Durvalumab is an immunotherapy drug called an immune checkpoint inhibitor. It blocks the protein[…]

A Mesothelioma Blood Test Could Improve Patient Quality of Life

December 3, 2021

A blood test for mesothelioma could help increase the time between CT scan appointments. The typical way doctors test to see if a treatment is working is called mRECIST, which[…]

Follow Up Care for Mesothelioma

November 19, 2021

Follow-up care is crucial for treating mesothelioma patients. A study out of the United Kingdom found that when patients receive follow-up care, more input from their caregivers, continuity, and more[…]

Skip to content